You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The World Health Organization has updated its list of essential medicines, Reuters reports.
The commission will develop a framework for scientists, clinicians, and regulatory authorities on the appropriate use of human germline genome editing.
A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.
The World Health Organization has announced that it would be making some organizational changes, the New York Times reports.
CRISPR technology has made its way around the world, but in the wake of the He Jiankui controversy, the industry is asking what recourse it has against misuse.
The World Health Organization has announced the members of its gene-editing committee, according to NPR.
Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.
The World Health Organization is putting together a panel of experts to develop guidelines and standards for gene editing, according to Reuters.
With WHO prequalification, global health organizations can consider the Aptima HIV-1 Quant Dx for public-sector procurement in resource-limited countries.
The study is the first to demonstrate the design features and operational characteristics of Cepheid's Xpert MTB/RIF Ultra assay.
Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.
The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.
In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.
According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.